Clinical manifestations associated with acute viral gastroenteritis pathogens among pediatric patients in Qatar.
Acute Disease
/ epidemiology
Child, Preschool
Coinfection
/ epidemiology
Feces
/ virology
Female
Gastroenteritis
/ epidemiology
Hospitalization
/ statistics & numerical data
Humans
Infant
Infant, Newborn
Male
Qatar
/ epidemiology
Severity of Illness Index
Virus Diseases
/ epidemiology
Viruses
/ classification
acute gastroenteritis infection
clinical manifestations
coinfection
disease severity
mixed infection
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
24
01
2021
received:
21
09
2020
accepted:
01
02
2021
pubmed:
10
2
2021
medline:
15
12
2021
entrez:
9
2
2021
Statut:
ppublish
Résumé
Acute gastroenteritis (AGE) remains a significant cause of diarrhea that affects children worldwide. It is usually caused by viral agents, including rotavirus (RV), norovirus (NoV), adenovirus (AdV), astrovirus (AstV), and sapovirus (SaV), and the disease severity varies accordingly. Here, we report the association of clinical severity among AGE-infected pediatrics caused by a single viral pathogen, coinfection (viral-viral), mixed infection (viral-bacterial), and AGE-negative samples. A total of 901 pediatric patients were admitted with AGE to the Pediatric Emergency Center of Hamad Medical Corporation in Qatar from June 2016 to June 2018. The age of the subjects ranged between 3 months and 14 years (median of 16 months). Virus antigens detection was performed by using Film Array Gastrointestinal (GI) Panel kit. AGE severity was assessed using the Vesikari Clinical Severity Scoring System. Multivariable multinomial logistic regression was used to model the five AGE viral agents' likelihood in relation to severity versus co-infection, mixed infection, and AGE-negative samples. AGE was most common in pediatrics aged 1-3 years (median age = 1.25 years) and more frequent in males than females, with a ratio of 1:0.8. About 19.2% of the infections were caused by NoV, followed by RV (18.2%), AdV (6.5%), SaV (2.3%), and AstV (1.8%). The majority of viral agents were detected higher in mixed infection (32.1%) than coinfection (4.9%). Based on the Vesikari score system, severe clinical illness was recorded among pediatrics infected with RV (82.2%) and NoV (75.7%). Further on multivariable analysis, compared to testing negative, the odds of detecting RV was three times significantly higher in children with severe symptoms relative to those with moderate (adjusted-odds ratio [a-OR] = 3.10; 95% confidence interval [CI] = 1.82-5.28). Similar results were observed when considering RV relative to co-infection and mixed infection (a-OR = 2.59; 95% CI = 1.23-5.48 and a-OR = 2.06; 1.28-3.30, respectively). About one-third of the study sample were Qatari children with AGE (33%), whereas 35% and 32% were pediatrics from the Middle East and North Africa region, excluding Qatari and nonregions. This study underlines the association of disease severity among AGE-infected pediatrics in Qatar. The overall Vesikari median score was significantly high, followed by more frequent hospitalization among RV-infected pediatrics compared to others. There was no reduction in the disease severity among RV-infected regardless of the vaccine dose.
Sections du résumé
BACKGROUND
Acute gastroenteritis (AGE) remains a significant cause of diarrhea that affects children worldwide. It is usually caused by viral agents, including rotavirus (RV), norovirus (NoV), adenovirus (AdV), astrovirus (AstV), and sapovirus (SaV), and the disease severity varies accordingly. Here, we report the association of clinical severity among AGE-infected pediatrics caused by a single viral pathogen, coinfection (viral-viral), mixed infection (viral-bacterial), and AGE-negative samples.
METHODS
A total of 901 pediatric patients were admitted with AGE to the Pediatric Emergency Center of Hamad Medical Corporation in Qatar from June 2016 to June 2018. The age of the subjects ranged between 3 months and 14 years (median of 16 months). Virus antigens detection was performed by using Film Array Gastrointestinal (GI) Panel kit. AGE severity was assessed using the Vesikari Clinical Severity Scoring System. Multivariable multinomial logistic regression was used to model the five AGE viral agents' likelihood in relation to severity versus co-infection, mixed infection, and AGE-negative samples.
RESULTS
AGE was most common in pediatrics aged 1-3 years (median age = 1.25 years) and more frequent in males than females, with a ratio of 1:0.8. About 19.2% of the infections were caused by NoV, followed by RV (18.2%), AdV (6.5%), SaV (2.3%), and AstV (1.8%). The majority of viral agents were detected higher in mixed infection (32.1%) than coinfection (4.9%). Based on the Vesikari score system, severe clinical illness was recorded among pediatrics infected with RV (82.2%) and NoV (75.7%). Further on multivariable analysis, compared to testing negative, the odds of detecting RV was three times significantly higher in children with severe symptoms relative to those with moderate (adjusted-odds ratio [a-OR] = 3.10; 95% confidence interval [CI] = 1.82-5.28). Similar results were observed when considering RV relative to co-infection and mixed infection (a-OR = 2.59; 95% CI = 1.23-5.48 and a-OR = 2.06; 1.28-3.30, respectively). About one-third of the study sample were Qatari children with AGE (33%), whereas 35% and 32% were pediatrics from the Middle East and North Africa region, excluding Qatari and nonregions.
CONCLUSION
This study underlines the association of disease severity among AGE-infected pediatrics in Qatar. The overall Vesikari median score was significantly high, followed by more frequent hospitalization among RV-infected pediatrics compared to others. There was no reduction in the disease severity among RV-infected regardless of the vaccine dose.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4794-4804Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
World Health Organization. Diarrhoeal disease. Key facts. 2017. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
Wikswo ME , Desai R , Edwards KM , et al. Clinical profile of children with norovirus disease in rotavirus vaccine era. Emerging Infect Dis. 2013;19(10):1691-1693.
Choi UY , Lee SY , Ma SH , et al. Epidemiological changes in rotavirus gastroenteritis in children under 5 years of age after the introduction of rotavirus vaccines in Korea. Eur J Pediatr. 2013;172(7):947-952.
Parashar UD , Gibson CJ , Bresee JS , Glass RI . Rotavirus and severe childhood diarrhea. Emerging Infect Dis. 2006;12(2):304-306.
Staat MA , Azimi PH , Berke T , et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21(3):221-227.
Riera-Montes M , O'Ryan M , Verstraeten T . Norovirus and rotavirus disease severity in children: systematic review and meta-analysis. Pediatr Infect Dis J. 2018;37(6):501-505.
Sultan MA , Hassan Z . Assessment of severity of acute gastroenteritis in the paediatric Pakistani population by modified Vesikari score. J Pak Med Assoc. 2018;68(2):159-164.
Saluja T , Dhingra MS , Sharma SD , et al. Association of rotavirus strains and severity of gastroenteritis in Indian children. Hum Vaccines Immunother. 2017;13(3):711-716.
Quintero-Ochoa G , Romero-Argüelles R , Aviles-Hernández A , et al. Viral agents of gastroenteritis and their correlation with clinical symptoms in rotavirus-vaccinated children. Infect Genet Evol. 2019;73:190-196.
Vesikari T , Rautanen T , Varis T , Beards GM , Kapikian AZ . Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am J Diseases Children (1960). 1990;144(3):285-289.
StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019.
Kargar M , Zare M , Najafi A . Molecular Epidemiology of Rotavirus Strains Circulating among Children with Gastroenteritis in Iran. Iran J Ped. 2012;22(1):63-69.
Al-Thani A , Baris M , Al-Lawati N , Al-Dhahry S . Characterising the aetiology of severe acute gastroenteritis among patients visiting a hospital in Qatar using real-time polymerase chain reaction. BMC Infect Dis. 2013;13:329.
Salami A , Fakih H , Chakkour M , Salloum L , Bahmad HF , Ghssein G . Prevalence, risk factors and seasonal variations of different Enteropathogens in Lebanese hospitalized children with acute gastroenteritis. BMC Pediatr. 2019;19(1):137.
Ghssein G , Salami A , Salloum L , Chedid P , Joumaa WH , Fakih H . Surveillance study of acute gastroenteritis etiologies in hospitalized children in south lebanon (SAGE study). Pediatr Gastroenterol Hepatol Nutr. 2018;21(3):176-183.
Behrman RE , Vaughan VC III . Nelson Textbook of Pediatrics. London: WB Saunders Company; 1983.
Kliegman RM , Behrman RE , Jenson HB , Stanton BM . Nelson textbook of pediatrics e-book. Elsevier Health Sciences; 2007.
Khalil M , Azhar E , Moujahed K , et al. Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007-2008. Clin Epidemiol. 2015;7:129-137.
Abugalia M , Cuevas L , Kirby A , et al. Clinical features and molecular epidemiology of rotavirus and norovirus infections in Libyan children. J Med Virol. 2011;83(10):1849-1856.
Benhafid M , Rguig A , Trivedi T , et al. Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease. Vaccine. 2012;30(46):6515-6520.
Benhafid M , Elomari N , Elqazoui M , et al. Diversity of rotavirus strains circulating in children under 5 years of age admitted to hospital for acute gastroenteritis in Morocco, June 2006 to May 2009. J Med Virol. 2013;85(2):354-362.
Alani QA . Common Rotavirus gastroenteritis in children under 5 years in maternity and children teaching hospital, western Iraq. Al-Anbar Medical J. 2012;10(1):1-7.
Kaplan NM , Kirby A , Abd-Eldayem SA , et al. Detection and molecular characterisation of rotavirus and norovirus infections in Jordanian children with acute gastroenteritis. Arch Virol. 2011;156(8):1477-1480.
Tayeb HT , Balkhy HH , Aljuhani SM , Elbanyan E , Alalola S , Alshaalan M . Increased prevalence of rotavirus among children associated gastroenteritis in Riyadh Saudi Arabia. Virol J. 2011;8:548.
El-Shabrawi M , Salem M , Abou-Zekri M , et al. The burden of different pathogens in acute diarrhoeal episodes among a cohort of Egyptian children less than five years old. Prz Gastroenterol. 2015;10(3):173-180.
Chhabra P , Payne DC , Szilagyi PG , et al. Etiology of viral gastroenteritis in children < 5 years of age in the United States, 2008-2009. J Infect Dis. 2013;208(5):790-800.
Payne DC , Vinjé J , Szilagyi PG , et al. Norovirus and medically attended gastroenteritis in US children. N Engl J Med. 2013;368(12):1121-1130.
Zambruni M , Luna G , Silva M , et al. High prevalence and increased severity of norovirus mixed infections among children 12-24 months of age living in the suburban areas of Lima, Peru. J Pediatric Infect Dis Soc. 2016;5(3):337-341.
O'Ryan M , Riera-Montes M , Lopman B . Norovirus in Latin America: systematic review and meta-analysis. Pediatr Infect Dis J. 2017;36(2):127-134.
Romero C , Tinoco YO , Loli S , et al. incidence of norovirus-associated diarrhea and vomiting disease among children and adults in a community cohort in the Peruvian Amazon Basin. Clin Infect Dis. 2017;65(5):833-839.
Jin HI , Lee YM , Choi YJ , Jeong SJ . Recent viral pathogen in acute gastroenteritis: a retrospective study at a tertiary hospital for 1 year. Korean J Pediatr. 2016;59(3):120.
Doll MK , Gagneur A , Tapiéro B , et al. Temporal changes in pediatric gastroenteritis after rotavirus vaccination in Quebec. Pediatr Infect Dis J. 2016;35(5):555-560.
Lopman BA , Steele D , Kirkwood CD , Parashar UD . The vast and varied global burden of norovirus: prospects for prevention and control. PLOS Med. 2016;13(4):e1001999.
Chung JY , Huh K , Kim SW , et al. Molecular epidemiology of human astrovirus infection in hospitalized children with acute gastroenteritis. Korean J Pediatr Gastroenterol Nutr. 2006;9(2):139.
Kowalzik F , Riera-Montes M , Verstraeten T , Zepp F . The burden of Norovirus disease in children in the European Union. Pediatr Infect Dis J. 2015;34(3):229-234.
Yi J , Sederdahl BK , Wahl K , et al. Rotavirus and Norovirus in pediatric healthcare-associated gastroenteritis. Open Forum Infect Dis. 2016;3(4).
Giaquinto C , Van Damme P , Huet F , et al. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis. 2007;195(Suppl_1):S26-S35.
Karadag A , Cibali Acikgoz Z , Avci Z , et al. Childhood diarrhoea in Ankara, Turkey: epidemiological and clinical features of rotavirus-positive versus rotavirus-negative cases. Scand J Infect Dis. 2005;37(4):269-275.
Sivan Perl M , Michael Goldman M , Matitiahu Berkovitch M , Eran , Kozer M . Characteristics of rotavirus gastroenteritis in hospitalized children in Israel. Pulse (average). 2011;100(100):0.58
Lorrot M , Bon F , El Hajje M-J , et al. Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian Hospital France. Eur J Clin Microbiol Infectious Diseases. 2011;30(3):361-368.
Tafalla M , Gardovska D , Gopala K , Kozlovska L . Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis. Hum Vaccines Immunother. 2019;15(6):1272-1278.
Wang FT , Mast TC , Glass RJ , Loughlin J , Seeger JD . Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Pediatr Infect Dis J. 2013;32(3):278-283.